Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 206 participants.
Also called NCT01692379
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 206 participants
- Sponsor
- Registry
-
NCT01692379
-
- Other papers using this trial's data
- Association Between Time to Reperfusion and Outcome Is Primarily Driven by the Time From Imaging to Reperfusion
- Endovascular treatment improves cognition after stroke: A secondary analysis of REVASCAT trial
- Phone and Video-Based Modalities of Central Blinded Adjudication of Modified Rankin Scores in an Endovascular Stroke Trial
- Posttreatment Infarct Volumes when Compared with 24-Hour and 90-Day Clinical Outcomes: Insights from the REVASCAT Randomized Controlled Trial
- Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial
- Thrombectomy within 8 hours after symptom onset in ischemic stroke
- Vessel Patency at 24 Hours and Its Relationship With Clinical Outcomes and Infarct Volume in REVASCAT Trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Terminated
Technical summary
Registry record NCT01692379. Randomized; single masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2015-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours
- Acronym
- REVASCAT
- Condition
- Acute Stroke
- Intervention (Device)
- Solitaire FR device
- Intervention (Other)
- Medical treatment
- Lead sponsor
- Fundacio Ictus Malaltia Vascular
- Collaborator
- Medtronic - MITG
Record details
- Record id
cardio:ct-nct01692379- Content hash
d1b43c624f197fc9d41e4780265a48ecb86bd09a03ad6ac0ae0d875ef7cf7cd9